Acura Pharmaceuticals Inc ACUR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.01–0.01
- 52-Week Range
- $0.00–0.05
- Bid/Ask
- $0.25 / $0.50
- Market Cap
- $660,017.83
- Volume/Avg
- 20,040 / 3,403
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Acura Pharmaceuticals Inc is a specialty pharmaceutical company based in the United States. It is engaged in the research, development, and commercialization of technologies and products intended to address medication abuse and misuse. The company's product portfolio includes Limitx, Oxaydo, and Nexafed.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 9
- Website
- http://www.acurapharm.com
Valuation
|
Metric
|
ACUR
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
ACUR
Financial Strength
|
Metric
|
ACUR
|
|---|---|
Quick Ratio | 0.43 |
Current Ratio | 0.72 |
Interest Coverage | −3.40 |
Quick Ratio
ACUR
Profitability
|
Metric
|
ACUR
|
|---|---|
Return on Assets (Normalized) | −83.74% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −213.60% |
Return on Assets
ACUR
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Fhrkqlglgs | Cfxszw | $70.9 Bil | |
ZTS
| Zoetis Inc Class A | Llbyznbsp | Msbj | $68.9 Bil | |
HLN
| Haleon PLC ADR | Xyvbndnym | Gdjwq | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Kbnwshshy | Ghjr | $14.7 Bil | |
VTRS
| Viatris Inc | Pscnkxnp | Gvgqj | $13.7 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Qwcrxfhys | Mxbsb | $11.9 Bil | |
CTLT
| Catalent Inc | Xnrvdbz | Lzshks | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Nqhwhbvr | Smlwz | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Rxcdsmgtv | Sxd | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Mwdxwqmb | Sqgblvw | $3.5 Bil |